CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $21.68M, lower than 95% of all stocks globally
- PositionOperating margin is -459.5%, lower than 95% of its Diagnostics & Research peers (median 5%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
16.06MGBP21.68M · vs all stocks (USD)
Revenue (TTM)
1.17MGBP1.59M · vs all stocks (USD)
Profit Margin
0.00%vs Diagnostics & Research peers
Beta
0.9890xvs all stocks
52-Week Change
-14.89%vs all stocks
Market Capitalization
16.06MGBP21.68M · vs all stocks (USD)
Enterprise Value
10.41MGBP14.06M · vs all stocks (USD)
Forward P/E
0.0048xvs Diagnostics & Research peers
Price to Sales (TTM)
13.68xvs Diagnostics & Research peers
Enterprise to Revenue
8.87xvs Diagnostics & Research peers
Enterprise to EBITDA
-1.93xvs Diagnostics & Research peers
Profit Margin
0.00%vs Diagnostics & Research peers
Operating Margin
-459.47%vs Diagnostics & Research peers
Return on Assets (TTM)
-117.82%vs Diagnostics & Research peers
Revenue (TTM)
1.17MGBP1.59M · vs all stocks (USD)
Revenue per Share (TTM)
0.0020GBPUpdated Aug 2, 2026Quarterly Revenue Growth
62.90%vs Diagnostics & Research peers
Gross Profit (TTM)
-3.33MGBP-4.50M · vs all stocks (USD)
EBITDA (TTM)
-5.38MGBP-7.27M · vs all stocks (USD)
Net Income (TTM)
-5.34MGBP-7.22M · vs all stocks (USD)
Operating Cash Flow (TTM)
-3.89MGBP-5.26M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-2.04MGBP-2.75M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00GBPUpdated Aug 2, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
764.00KGBPFY2025 · Jun 30, 2025Operating Income
-5.38MGBP-7.27M · vs all stocks (USD)
Pre-tax Income
-5.43MGBPFY2025 · Jun 30, 2025Income Tax Expense
-195.00KGBPFY2025 · Jun 30, 2025Net Income
-5.23MGBPFY2025 · Jun 30, 2025EBIT
-5.43MGBPFY2025 · Jun 30, 2025EBITDA (Income Statement)
-5.36MGBPFY2025 · Jun 30, 2025Research & Development
4.23MGBPFY2025 · Jun 30, 2025Selling, General & Administrative
2.10MGBPFY2025 · Jun 30, 2025Non-operating Interest Income
43.00KGBPFY2025 · Jun 30, 2025Non-operating Interest Expense
0.00GBPFY2025 · Jun 30, 2025EPS (Basic)
-0.0090GBPFY2025 · Jun 30, 2025EPS (Diluted)
-0.0090GBPFY2025 · Jun 30, 2025Basic Shares Outstanding
562.85MSharesFY2025 · Jun 30, 2025Diluted Shares Outstanding
562.85MSharesFY2025 · Jun 30, 2025Preferred Stock Dividends
0.00GBPFY2025 · Jun 30, 2025Operating Cash Flow
-5.64MGBPFY2025 · Jun 30, 2025Free Cash Flow
-5.66MGBPFY2025 · Jun 30, 2025Cash & Cash Equivalents (End of Period)
1.18MGBPFY2025 · Jun 30, 2025Starting Profit (CF Statement)
-5.43MGBPFY2025 · Jun 30, 2025Stock-based Compensation
84.00KGBPFY2025 · Jun 30, 2025Other Non-cash Items
46.00KGBPFY2025 · Jun 30, 2025Change in Accounts Receivable (CF)
-297.00KGBPFY2025 · Jun 30, 2025Change in Other Assets/Liabilities
-47.00KGBPFY2025 · Jun 30, 2025Capital Expenditures
-23.00KGBPFY2025 · Jun 30, 2025Net Investing Cash Flow
-23.00KGBPFY2025 · Jun 30, 2025Net Financing Cash Flow
1.23MGBPFY2025 · Jun 30, 2025Shares Outstanding
1.04BSharesUpdated Aug 2, 2026Float Shares
561.10MSharesUpdated Aug 2, 2026% Held by Insiders
63.50%vs all stocks
% Held by Institutions
1.31%vs all stocks
Total Cash (MRQ)
387.00KGBP522.66K · vs all stocks (USD)
Total Cash per Share (MRQ)
0.00GBPUpdated Aug 2, 2026Total Debt (MRQ)
500.00KGBP675.26K · vs all stocks (USD)
Current Ratio (MRQ)
0.9860xvs Diagnostics & Research peers
Book Value per Share (MRQ)
0.00GBPUpdated Aug 2, 2026Total Assets
2.81MGBP3.80M · vs all stocks (USD)
Total Current Assets
2.69MGBPFY2025 · Jun 30, 2025Total Liabilities
1.38MGBPFY2025 · Jun 30, 2025Total Non-current Assets
130.00KGBPFY2025 · Jun 30, 2025Total Non-current Liabilities
0.00GBPFY2025 · Jun 30, 2025Total Current Liabilities
1.38MGBPFY2025 · Jun 30, 2025Cash
1.18MGBPFY2025 · Jun 30, 2025Cash & Cash Equivalents
1.18MGBPFY2025 · Jun 30, 2025Accounts Receivable
253.00KGBPFY2025 · Jun 30, 2025Inventory
428.00KGBPFY2025 · Jun 30, 2025Accounts Payable
589.00KGBPFY2025 · Jun 30, 2025Short-term Debt
0.00GBPFY2025 · Jun 30, 2025Common Stock (Book)
9.37MGBPFY2025 · Jun 30, 2025Retained Earnings
-62.67MGBPFY2025 · Jun 30, 2025Total Shareholders' Equity
1.44MGBP1.94M · vs all stocks (USD)
52-Week Low
0.1900GBXUpdated Aug 2, 202652-Week High
1.50GBXUpdated Aug 2, 202652-Week Change
-14.89%vs all stocks
Beta
0.9890xvs all stocks
50-Day MA
1.20GBXUpdated Aug 2, 2026200-Day MA
1.03GBXUpdated Aug 2, 2026Avg 10-Day Volume
3.65MSharesUpdated Aug 2, 2026Avg 30-Day Volume
4.25MSharesUpdated Aug 2, 2026Diluted EPS (TTM)
-0.0100GBPUpdated Aug 2, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -459.5%, lower than 95% of its Diagnostics & Research peers (median 5%)Significant
Operating margin: -4.59Industry median: 0.05Industry P5: -0.34Peers compared: 31.00
Return on assets is -117.8%, lower than 95% of its Diagnostics & Research peers (median 0.4%)Significant
Return on assets: -1.18Industry median: 0.00Industry P5: -0.42Peers compared: 31.00
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $21.68M, lower than 95% of all stocks globallySignificant
Market cap (USD): 21,683,680.968Global P5: 269,387,740.27
Revenue is $1.59M, lower than 95% of all stocks globallySignificant
Revenue (USD): 1,585,522.22Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Northern Bear Plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kropz PLC
Tier 1ProductionThroughput-Bound ConversionFlowRule
CelLBxHealth plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Light Science Technologies Holdings plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Haydale Graphene Industries plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Harvard Bioscience, Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Eco Buildings Group plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Directa Plus Plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Abingdon Health plc
Tier 1ProductionThroughput-Bound ConversionRule
Eenergy Group Plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
A2Z Cust2Mate Solutions Corp
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Beam Therapeutics Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Wave Life Sciences Ltd.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC